These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 35187035)

  • 1. Omega-3 Fatty Acid Supplementation and Coronary Heart Disease Risks: A Meta-Analysis of Randomized Controlled Clinical Trials.
    Shen S; Gong C; Jin K; Zhou L; Xiao Y; Ma L
    Front Nutr; 2022; 9():809311. PubMed ID: 35187035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colchicine and coronary heart disease risks: A meta-analysis of randomized controlled clinical trials.
    Ma Z; Chen J; Jin K; Chen X
    Front Cardiovasc Med; 2022; 9():947959. PubMed ID: 36176989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of sodium-glucose cotransporter 2 inhibitors with cardiovascular outcome and safety events: A meta-analysis of randomized controlled clinical trials.
    Gong C; Shen SC; Zhang K; Zhou L; Shen JJ; Zhao JY; Ding SG; Ma LK; Gao H
    Front Cardiovasc Med; 2022; 9():926979. PubMed ID: 36312269
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of omega-3 fatty acids on coronary revascularization and cardiovascular events: a meta-analysis.
    Dinu M; Sofi F; Lotti S; Colombini B; Mattioli AV; Catapano AL; Casula M; Baragetti A; Wong ND; Steg PG; Ambrosio G
    Eur J Prev Cardiol; 2024 Jun; ():. PubMed ID: 38869144
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tongxinluo capsule as supplementation and cardiovascular endpoint events in patients with coronary heart disease: A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials.
    Lv J; Liu S; Guo S; Gao J; Song Q; Cui X
    J Ethnopharmacol; 2022 May; 289():115033. PubMed ID: 35091010
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of omega-3 fatty acids on cardiovascular outcomes: A systematic review and meta-analysis.
    Khan SU; Lone AN; Khan MS; Virani SS; Blumenthal RS; Nasir K; Miller M; Michos ED; Ballantyne CM; Boden WE; Bhatt DL
    EClinicalMedicine; 2021 Aug; 38():100997. PubMed ID: 34505026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Omega-3 polyunsaturated fatty acids supplementation and cardiovascular outcomes: do formulation, dosage, and baseline cardiovascular risk matter? An updated meta-analysis of randomized controlled trials.
    Casula M; Olmastroni E; Gazzotti M; Galimberti F; Zambon A; Catapano AL
    Pharmacol Res; 2020 Oct; 160():105060. PubMed ID: 32634581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marine Omega-3 Supplementation and Cardiovascular Disease: An Updated Meta-Analysis of 13 Randomized Controlled Trials Involving 127 477 Participants.
    Hu Y; Hu FB; Manson JE
    J Am Heart Assoc; 2019 Oct; 8(19):e013543. PubMed ID: 31567003
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks: Meta-analysis of 10 Trials Involving 77 917 Individuals.
    Aung T; Halsey J; Kromhout D; Gerstein HC; Marchioli R; Tavazzi L; Geleijnse JM; Rauch B; Ness A; Galan P; Chew EY; Bosch J; Collins R; Lewington S; Armitage J; Clarke R;
    JAMA Cardiol; 2018 Mar; 3(3):225-234. PubMed ID: 29387889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Omega-6 fatty acids and the risk of cardiovascular disease: insights from a systematic review and meta-analysis of randomized controlled trials and a Mendelian randomization study.
    Mazidi M; Shekoohi N; Katsiki N; Banach M
    Arch Med Sci; 2022; 18(2):466-479. PubMed ID: 35316920
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and Safety of Omega-3 Fatty Acids in the Prevention of Cardiovascular Disease: A Systematic Review and Meta-analysis.
    Yan J; Liu M; Yang D; Zhang Y; An F
    Cardiovasc Drugs Ther; 2022 Sep; ():. PubMed ID: 36103100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of omega-3 fatty acids supplementation on the prognosis of coronary artery disease: A meta-analysis of randomized controlled trials.
    Chao T; Sun J; Ge Y; Wang C
    Nutr Metab Cardiovasc Dis; 2024 Mar; 34(3):537-547. PubMed ID: 38161115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Omega-3 Dosage on Cardiovascular Outcomes: An Updated Meta-Analysis and Meta-Regression of Interventional Trials.
    Bernasconi AA; Wiest MM; Lavie CJ; Milani RV; Laukkanen JA
    Mayo Clin Proc; 2021 Feb; 96(2):304-313. PubMed ID: 32951855
    [TBL] [Abstract][Full Text] [Related]  

  • 14. All-Cause Mortality and Cardiovascular Death between Statins and Omega-3 Supplementation: A Meta-Analysis and Network Meta-Analysis from 55 Randomized Controlled Trials.
    Kim J; Hoang T; Kim JM; Bu SY; Choi JH; Park E; Lee SM; Park E; Min JY; Lee IS; Youn SY; Yeon JY
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33092130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative Effect of Statins and Omega-3 Supplementation on Cardiovascular Events: Meta-Analysis and Network Meta-Analysis of 63 Randomized Controlled Trials Including 264,516 Participants.
    Hoang T; Kim J
    Nutrients; 2020 Jul; 12(8):. PubMed ID: 32722395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive evaluation of time-varied outcomes for invasive and conservative strategies in patients with NSTE-ACS: a meta-analysis of randomized controlled trials.
    Zhao YJ; Sun Y; Wang F; Cai YY; Alolga RN; Qi LW; Xiao P
    Front Cardiovasc Med; 2023; 10():1197451. PubMed ID: 37745128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marine omega-3 fatty acid supplementation and prevention of cardiovascular disease: update on the randomized trial evidence.
    Bassuk SS; Manson JE;
    Cardiovasc Res; 2023 Jun; 119(6):1297-1309. PubMed ID: 36378553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevention of sudden cardiac death with omega-3 fatty acids in patients with coronary heart disease: a meta-analysis of randomized controlled trials.
    Zhao YT; Chen Q; Sun YX; Li XB; Zhang P; Xu Y; Guo JH
    Ann Med; 2009; 41(4):301-10. PubMed ID: 19148838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Omega 3 Fatty acids and cardiovascular outcomes: systematic review and meta-analysis.
    Kotwal S; Jun M; Sullivan D; Perkovic V; Neal B
    Circ Cardiovasc Qual Outcomes; 2012 Nov; 5(6):808-18. PubMed ID: 23110790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association between omega-3 fatty acid supplementation and risk of major cardiovascular disease events: a systematic review and meta-analysis.
    Rizos EC; Ntzani EE; Bika E; Kostapanos MS; Elisaf MS
    JAMA; 2012 Sep; 308(10):1024-33. PubMed ID: 22968891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.